Is CT-based screening for lung cancer finally ready for prime time? Source: Annual Congress 2012 - PG18 Recent evolutions in screening and early diagnosis of lung cancer Year: 2012
Our diagnostic time for lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 322s Year: 2005
CT screening for lung cancer: is it ready for prime time yet or how to enhance pre-test probability? Source: International Congress 2017 – The latest in lung cancer Year: 2017
Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring? Source: Breathe, 16 (4) 200204; 10.1183/20734735.0204-2020 Year: 2020
An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Year: 2006
Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes Source: Eur Respir J 2010; 35: 146-151 Year: 2010
Cannabis use and lung cancer: time to stop overlooking the problem? Source: Eur Respir J, 57 (5) 2004132; 10.1183/13993003.04132-2020 Year: 2021
Evolution in the diagnostic approach to lung cancer Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021
Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times Source: Eur Respir J, 51 (6) 1800602; 10.1183/13993003.00602-2018 Year: 2018
Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times Source: Eur Respir J, 51 (6) 1800844; 10.1183/13993003.00844-2018 Year: 2018
Check point inhibitors in peri-operative non small cell lung cancer strategy Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies? Year: 2017
Validation of a gene-based lung cancer risk test (Respiragene) for high risk smokers: A targeted approach to early detection of lung cancer Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010
Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients? Source: Eur Respir J 2002; 19: 464-468 Year: 2002
Factors determining early adherence to a lung cancer screening protocol Source: Eur Respir J 2007; 30: 532-537 Year: 2007
Modern methods of diagnostics in screening of the COPD candidates for lung volume reduction surgery Source: Eur Respir J 2006; 28: Suppl. 50, 274s Year: 2006
Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019
Implementation of lung cancer screening in Europe: the way forward Source: Virtual Congress 2020 – Thoracic oncology Year: 2020
The ALA/ATS implementation guide on lung cancer screening Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance! Year: 2018
Diagnostic delay time of lung cancer in a community study Source: Annual Congress 2008 - Various aspects of thoracic oncology Year: 2008
Tele-cancer: Reducing time-to-treatment for patients with lung cancer Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018